Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki

The Laser Clinic S.C. conducts research on Atopic Dermatitis, aiming to test innovative treatments that reduce skin lesions and improve quality of life.

• Evaluation of new topical and systemic agents
• Use of patient‑reported outcome scales
• Exploration of disease‑specific biomarkers

Current studies target the Eczema Area and Severity Index (EASI‑75) as a primary endpoint to demonstrate meaningful clinical benefit.

Investigations focus on the immune dysregulation in moderate to severe Atopic Dermatitis, assessing the safety and durability of systemic immunomodulators.

• Long‑term safety monitoring of oral agents
• Immune pathway profiling and response biomarkers
• Combination approaches with existing therapies

The goal is to expand therapeutic options by confirming sustained efficacy and tolerability of novel compounds such as RO7790121.